Clinico-biochemical Study of the Safety and Tolerability of Selective Serotonin Reuptake Inhibitors (SSRI) with Special Reference to SSRI Induced Hyponatremia in Humans and Animals
Introduction: Selective Serotonin Reuptake Inhibitors (SSRIs) are recommended as first-line anti-depressants in Major Depressive Disorder (MDD) because of their relatively benign safety profile. Hyponatremia is under reported and notorious adverse effect of SSRIs shown by few Randomised Clinical...
Main Authors: | Suhena Sarkar, Uttam Kumar Roy, Supreeti Biswas, Asim Kumar Mallick, PURNENDU MANDA |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2021-03-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://www.jcdr.net/articles/PDF/14641/48204_CE[Ra1]_F[SK]_PF1(AKA_SHU)_PN(KM).pdf |
Similar Items
-
THE SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) AS TREATMENT OF DEPRESSION IN PATIENTS WITH EPILEPSY
by: Yu. V. Solomatin, et al.
Published: (2016-12-01) -
Severe hyponatremia associated with escitalopram
by: Gautam Rawal, et al.
Published: (2017-01-01) -
A descriptive study of hyponatremia in a tertiary care hospital of Eastern India
by: Nandini Chatterjee, et al.
Published: (2012-01-01) -
A case report of rapid-onset hyponatremia induced by low-dose olanzapine
by: Sethulakshmi Sreevalsam Anil, et al.
Published: (2017-01-01) -
Severe hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with fluoxetine: case report
by: Carlos Alexandre Twardowschy, et al.
Published: (2006-03-01)